Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Annexon, Inc.ANNX · Entity 5011 | Director · PRESIDENT AND CEO | September 24, 2026 | September 25, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Annexon, Inc.
Report date September 24, 2026 · Filed September 25, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 390,476 |
Reported balance
After 2026-09-24 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-09-24 · Purchase · Acquired 26,065 · Balance 390,476 F1: This transaction was executed in multiple trades in prices ranging from $3.815 to $3.829, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote. F2: Includes 4,579 shares acquired on May 15, 2025 and 8,278 shares acquired on May 15, 2026, pursuant to the Issuer's Employee Stock Purchase Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple trades in prices ranging from $3.815 to $3.829, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote.
F2: Includes 4,579 shares acquired on May 15, 2025 and 8,278 shares acquired on May 15, 2026, pursuant to the Issuer's Employee Stock Purchase Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 24, 2026 Filed Sep 25, 2026 20:15 UTC | Annexon, Inc. ANNX · Entity 5011 | PurchaseCommon Stock | 26,065 | $3.83 | $99,828.95 |
DisclosureSEC source: 0001818520-26-000003 · form4-09252026_040908.xml · nonDerivative · entry 1 Love Douglas · CIK 0001818520 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 390,476 F1 · price: This transaction was executed in multiple trades in prices ranging from $3.815 to $3.829, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote. F2 · balance_after: Includes 4,579 shares acquired on May 15, 2025 and 8,278 shares acquired on May 15, 2026, pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 19:11 UTC | Annexon, Inc. ANNX · Entity 5011 | GrantStock Option (Right to Buy) · Derivative | 1,250,000 | $0.00 Strike: $5.10 | $0.00 |
DisclosureSEC source: 0001818520-26-000001 · form4-02242026_120218.xml · derivative · entry 1 Love Douglas · CIK 0001818520 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,250,000 Underlying: Common Stock · 1,250,000 shares Expires 2036-02-19 F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 19, 2026 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to Reporting Person's continuous service with the Issuer as of each such vesting date. Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 16:50 UTC | Annexon, Inc. ANNX · Entity 5011 | GrantStock Option (Right to Buy) · Derivative | 1,300,000 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001415889-25-006192 · form4-03032025_090314.xml · derivative · entry 1 Love Douglas · CIK 0001818520 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,300,000 Underlying: Common Stock · 1,300,000 shares Expires 2034-02-27 F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 27, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 16:30 UTC | Annexon, Inc. ANNX · Entity 5011 | SaleCommon Stock | 5,021 | $2.95 | $14,811.95 |
DisclosureSEC source: 0001415889-25-004434 · form4-02182025_040207.xml · nonDerivative · entry 1 Love Douglas · CIK 0001818520 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 351,554 F1 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). F2 · price: This transaction was executed in multiple trades in prices ranging from $2.87 to $3.0297, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| January 06, 2025 Filed Jan 8, 2025 17:58 UTC | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionStock Option (Right to Buy) · Derivative | 37,994 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001415889-25-001149 · form4-01082025_100151.xml · derivative · entry 2 Love Douglas · CIK 0001818520 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 37,994 shares Expires 2025-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| January 06, 2025 Filed Jan 8, 2025 17:58 UTC | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionCommon Stock | 37,994 | $1.41 | $53,556.34 |
DisclosureSEC source: 0001415889-25-001149 · form4-01082025_100151.xml · nonDerivative · entry 1 Love Douglas · CIK 0001818520 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 356,575 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 5,514 shares acquired on May 15, 2024 and 2,497 shares acquired on November 15, 2024, pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| October 30, 2024 Filed Nov 1, 2024 16:15 UTC | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionStock Option (Right to Buy) · Derivative | 36,050 | $0.00 Strike: $1.85 | $0.00 |
DisclosureSEC source: 0001415889-24-025902 · form4-11012024_041101.xml · derivative · entry 4 Love Douglas · CIK 0001818520 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,050 shares Expires 2026-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| October 30, 2024 Filed Nov 1, 2024 16:15 UTC | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionStock Option (Right to Buy) · Derivative | 78,399 | $0.00 Strike: $1.85 | $0.00 |
DisclosureSEC source: 0001415889-24-025902 · form4-11012024_041101.xml · derivative · entry 3 Love Douglas · CIK 0001818520 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 78,399 shares Expires 2026-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| October 30, 2024 Filed Nov 1, 2024 16:15 UTC | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionCommon Stock | 36,050 | $1.85 | $66,696.11 |
DisclosureSEC source: 0001415889-24-025902 · form4-11012024_041101.xml · nonDerivative · entry 2 Love Douglas · CIK 0001818520 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 310,570 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 30, 2024 Filed Nov 1, 2024 16:15 UTC | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionCommon Stock | 78,399 | $1.85 | $145,045.99 |
DisclosureSEC source: 0001415889-24-025902 · form4-11012024_041101.xml · nonDerivative · entry 1 Love Douglas · CIK 0001818520 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 274,520 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 16:32 UTC | Annexon, Inc. ANNX · Entity 5011 | GrantStock Option (Right to Buy) · Derivative | 656,200 | $0.00 Strike: $5.13 | $0.00 |
DisclosureSEC source: 0001415889-24-004629 · form4-02212024_040249.xml · derivative · entry 1 Love Douglas · CIK 0001818520 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 656,200 Underlying: Common Stock · 656,200 shares Expires 2034-02-16 F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 16, 2024 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 19:56 UTC | Annexon, Inc. ANNX · Entity 5011 | SaleCommon Stock | 5,782 | $5.54 | $32,032.28 |
DisclosureSEC source: 0001415889-24-003856 · form4-02152024_120225.xml · nonDerivative · entry 1 Love Douglas · CIK 0001818520 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 196,121 F1 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). F2 · price: This transaction was executed in multiple trades in prices ranging from $5.34 to $5.712, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F3 · balance_after: Includes 13,334 RSUs. F4 · balance_after: Includes 2,650 shares acquired on May 15, 2023 and 1,607 shares acquired on November 15, 2023, pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 17:28 UTC | Annexon, Inc. ANNX · Entity 5011 | GrantStock Option (Right to Buy) · Derivative | 345,000 | $0.00 Strike: $5.94 | $0.00 |
DisclosureSEC source: 0001567619-23-003427 · doc1.xml · derivative · entry 1 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 345,000 Underlying: Common Stock · 345,000 shares Expires 2033-02-16 F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 16, 2023 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 17:12 UTC | Annexon, Inc. ANNX · Entity 5011 | SaleCommon Stock | 6,571 | $5.87 | $38,563.88 |
DisclosureSEC source: 0001567619-23-003317 · doc1.xml · nonDerivative · entry 1 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,646 F1 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. F2 · price: This transaction was executed in multiple trades in prices ranging from $5.80 to $5.95, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F3 · balance_after: Includes 3,274 shares acquired on May 15, 2022 and 1 share acquired on November 15, 2022, pursuant to the Issuer's Employee Stock Purchase Plan. F4 · balance_after: Includes 26,667 restricted stock units. Read SEC document |
| July 11, 2022 Filed Jul 13, 2022 19:46 UTC | Annexon, Inc. ANNX · Entity 5011 | GrantStock Option (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $3.91 | $0.00 |
DisclosureSEC source: 0001567619-22-013998 · doc1.xml · derivative · entry 1 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2032-07-11 F1 · derivative.exercise_date: 1/36th of the shares subject to the option vest on each monthly anniversary measured from July 11, 2022 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date. Read SEC document |
| July 11, 2022 Filed Jul 13, 2022 19:05 UTC | Annexon, Inc. ANNX · Entity 5011 | GrantStock Option (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $3.91 | $0.00 |
DisclosureSEC source: 0001567619-22-013994 · doc1.xml · derivative · entry 1 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2032-07-11 F1 · derivative.exercise_date: 1/36th of the shares subject to the option vest on each monthly anniversary measured from July 11, 2022 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date. Read SEC document |
| July 11, 2022 Filed Jul 13, 2022 18:58 UTC | Annexon, Inc. ANNX · Entity 5011 | GrantStock Option (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $3.91 | $0.00 |
DisclosureSEC source: 0001567619-22-013992 · doc1.xml · derivative · entry 1 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2032-07-11 F1 · derivative.exercise_date: 1/36th of the shares subject to the option vest on each monthly anniversary measured from July 11, 2022 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date. Read SEC document |
| April 14, 2022 Filed Apr 18, 2022 19:04 UTC | Annexon, Inc. ANNX · Entity 5011 | PurchaseCommon Stock | 60,000 | $2.45 | $146,814.00 |
DisclosureSEC source: 0001567619-22-008630 · doc1.xml · nonDerivative · entry 1 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,942 F1 · price: The shares were purchased in multiple transactions at prices ranging from $2.41 to $2.50, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote. F2 · balance_after: Includes 160,942 shares held and 40,000 restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. Read SEC document |
| February 11, 2022 Filed Feb 15, 2022 16:39 UTC | Annexon, Inc. ANNX · Entity 5011 | GrantStock Option (Right to Buy) · Derivative | 320,000 | $0.00 Strike: $6.94 | $0.00 |
DisclosureSEC source: 0001567619-22-004615 · doc1.xml · derivative · entry 2 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 320,000 Underlying: Common Stock · 320,000 shares Expires 2032-02-11 F3 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 11, 2022 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
| February 11, 2022 Filed Feb 15, 2022 16:39 UTC | Annexon, Inc. ANNX · Entity 5011 | GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-004615 · doc1.xml · nonDerivative · entry 1 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,942 F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3rd of the RSUs vest annually on February 11 of each year, with the first 1/3rd vesting on February 11, 2023. F2 · balance_after: Includes 40,000 RSUs. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 18:05 UTC | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $1.85 | $0.00 |
DisclosureSEC source: 0001567619-21-020520 · doc1.xml · derivative · entry 4 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,449 Underlying: Common Stock · 30,000 shares Expires 2026-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 18:05 UTC | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionStock Option (Right to Buy) · Derivative | 70,942 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001567619-21-020520 · doc1.xml · derivative · entry 3 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 70,942 shares Expires 2025-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 18:05 UTC | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionCommon Stock | 30,000 | $1.85 | $55,503.00 |
DisclosureSEC source: 0001567619-21-020520 · doc1.xml · nonDerivative · entry 2 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,942 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 18:05 UTC | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionCommon Stock | 70,942 | $1.41 | $99,999.84 |
DisclosureSEC source: 0001567619-21-020520 · doc1.xml · nonDerivative · entry 1 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,942 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2021 Filed Sep 20, 2021 17:46 UTC | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001567619-21-017366 · doc1.xml · derivative · entry 3 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,994 Underlying: Common Stock · 7,500 shares Expires 2025-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| September 16, 2021 Filed Sep 20, 2021 17:46 UTC | Annexon, Inc. ANNX · Entity 5011 | SaleCommon Stock | 7,500 | $22.05 | $165,340.50 |
DisclosureSEC source: 0001567619-21-017366 · doc1.xml · nonDerivative · entry 2 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades in prices ranging from $22.00 to $22.26, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| September 16, 2021 Filed Sep 20, 2021 17:46 UTC | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionCommon Stock | 7,500 | $1.41 | $10,572.00 |
DisclosureSEC source: 0001567619-21-017366 · doc1.xml · nonDerivative · entry 1 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 08, 2021 Filed Jun 9, 2021 16:32 UTC | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,750 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001567619-21-011901 · doc1.xml · derivative · entry 6 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,494 Underlying: Common Stock · 3,750 shares Expires 2025-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option vest are fully vested and exercisable. Read SEC document |
| June 08, 2021 Filed Jun 9, 2021 16:32 UTC | Annexon, Inc. ANNX · Entity 5011 | SaleCommon Stock | 3,750 | $22.55 | $84,562.50 |
DisclosureSEC source: 0001567619-21-011901 · doc1.xml · nonDerivative · entry 4 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. Read SEC document |
| June 08, 2021 Filed Jun 9, 2021 16:32 UTC | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionCommon Stock | 3,750 | $1.41 | $5,286.00 |
DisclosureSEC source: 0001567619-21-011901 · doc1.xml · nonDerivative · entry 3 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 16:32 UTC | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,750 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001567619-21-011901 · doc1.xml · derivative · entry 5 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,244 Underlying: Common Stock · 3,750 shares Expires 2025-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option vest are fully vested and exercisable. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 16:32 UTC | Annexon, Inc. ANNX · Entity 5011 | SaleCommon Stock | 3,750 | $22.31 | $83,667.38 |
DisclosureSEC source: 0001567619-21-011901 · doc1.xml · nonDerivative · entry 2 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades in prices ranging from $22.02 to $22.69, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 16:32 UTC | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionCommon Stock | 3,750 | $1.41 | $5,286.00 |
DisclosureSEC source: 0001567619-21-011901 · doc1.xml · nonDerivative · entry 1 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 12:31 UTC | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionStock Option (Right to Buy) · Derivative | 500 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001567619-21-007429 · doc1.xml · derivative · entry 7 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,994 Underlying: Common Stock · 500 shares Expires 2025-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option vest are fully vested and exercisable. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 12:31 UTC | Annexon, Inc. ANNX · Entity 5011 | SaleCommon Stock | 300 | $28.01 | $8,403.00 |
DisclosureSEC source: 0001567619-21-007429 · doc1.xml · nonDerivative · entry 5 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 12:31 UTC | Annexon, Inc. ANNX · Entity 5011 | SaleCommon Stock | 200 | $28.19 | $5,638.00 |
DisclosureSEC source: 0001567619-21-007429 · doc1.xml · nonDerivative · entry 4 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300 F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 12:31 UTC | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionCommon Stock | 500 | $1.41 | $704.80 |
DisclosureSEC source: 0001567619-21-007429 · doc1.xml · nonDerivative · entry 3 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 12:31 UTC | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,102 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001567619-21-007429 · doc1.xml · derivative · entry 6 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,494 Underlying: Common Stock · 7,102 shares Expires 2025-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option vest are fully vested and exercisable. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 12:31 UTC | Annexon, Inc. ANNX · Entity 5011 | SaleCommon Stock | 7,102 | $28.11 | $199,620.89 |
DisclosureSEC source: 0001567619-21-007429 · doc1.xml · nonDerivative · entry 2 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades in prices ranging from $28.00 to $28.30, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 12:31 UTC | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionCommon Stock | 7,102 | $1.41 | $10,010.98 |
DisclosureSEC source: 0001567619-21-007429 · doc1.xml · nonDerivative · entry 1 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,102 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 30, 2021 Filed Mar 31, 2021 16:04 UTC | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,750 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001567619-21-007290 · doc1.xml · derivative · entry 9 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,596 Underlying: Common Stock · 3,750 shares Expires 2025-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The shares subject to the option vest are fully vested and exercisable. Read SEC document |
| March 30, 2021 Filed Mar 31, 2021 16:04 UTC | Annexon, Inc. ANNX · Entity 5011 | SaleCommon Stock | 1,850 | $24.78 | $45,850.96 |
DisclosureSEC source: 0001567619-21-007290 · doc1.xml · nonDerivative · entry 7 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F7 · price: This transaction was executed in multiple trades in prices ranging from $24.63 to $25.00, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| March 30, 2021 Filed Mar 31, 2021 16:04 UTC | Annexon, Inc. ANNX · Entity 5011 | SaleCommon Stock | 1,900 | $24.27 | $46,115.09 |
DisclosureSEC source: 0001567619-21-007290 · doc1.xml · nonDerivative · entry 6 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,850 F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F6 · price: This transaction was executed in multiple trades in prices ranging from $23.63 to $24.56, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| March 30, 2021 Filed Mar 31, 2021 16:04 UTC | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionCommon Stock | 3,750 | $1.41 | $5,286.00 |
DisclosureSEC source: 0001567619-21-007290 · doc1.xml · nonDerivative · entry 5 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 29, 2021 Filed Mar 31, 2021 16:04 UTC | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,750 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001567619-21-007290 · doc1.xml · derivative · entry 8 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,346 Underlying: Common Stock · 3,750 shares Expires 2025-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The shares subject to the option vest are fully vested and exercisable. Read SEC document |
| March 29, 2021 Filed Mar 31, 2021 16:04 UTC | Annexon, Inc. ANNX · Entity 5011 | SaleCommon Stock | 300 | $27.24 | $8,171.49 |
DisclosureSEC source: 0001567619-21-007290 · doc1.xml · nonDerivative · entry 4 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F4 · price: This transaction was executed in multiple trades in prices ranging from $27.03 to $27.515, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| March 29, 2021 Filed Mar 31, 2021 16:04 UTC | Annexon, Inc. ANNX · Entity 5011 | SaleCommon Stock | 600 | $26.42 | $15,851.04 |
DisclosureSEC source: 0001567619-21-007290 · doc1.xml · nonDerivative · entry 3 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300 F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F3 · price: This transaction was executed in multiple trades in prices ranging from $26.02 to $27.00, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| March 29, 2021 Filed Mar 31, 2021 16:04 UTC | Annexon, Inc. ANNX · Entity 5011 | SaleCommon Stock | 2,850 | $25.02 | $71,311.56 |
DisclosureSEC source: 0001567619-21-007290 · doc1.xml · nonDerivative · entry 2 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 900 F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades in prices ranging from $24.74 to $25.63, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| March 29, 2021 Filed Mar 31, 2021 16:04 UTC | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionCommon Stock | 3,750 | $1.41 | $5,286.00 |
DisclosureSEC source: 0001567619-21-007290 · doc1.xml · nonDerivative · entry 1 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 20:04 UTC | Annexon, Inc. ANNX · Entity 5011 | GrantStock Option (Right to Buy) · Derivative | 325,000 | $0.00 Strike: $30.07 | $0.00 |
DisclosureSEC source: 0001567619-21-005219 · doc1.xml · derivative · entry 1 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 325,000 Underlying: Common Stock · 325,000 shares Expires 2031-02-25 F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 25, 2021 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.